Alexander van Dijk

Alexander van Dijk has over 13 years of work experience in the finance and healthcare industries. From 2007 to 2009, they held positions as an Investment Banking Analyst at Credit Suisse and an Intern at ARK (Absolute Return for Kids). At Human Digital from 2009 to 2012, they were an Operations Officer and Data Analyst. From 2012 to 2013, they were an MBA Intern at Biogen Idec and a Manager, Business Operations at Biogen from 2013 to 2016. From 2016 to 2020, they held various roles at Alexion Pharmaceuticals, Inc., including Director, Head of R&D Finance, Associate Director, Corporate Finance, and Associate Director, Long Range Planning, Corporate Finance. Most recently, they were a Senior Director, Strategic Planning & Chief of Staff to Chief Medical Officer and Senior Director, Strategic Planning & Decisions Analysis, R&D at Sunovion Pharmaceuticals from 2020 to 2022. Alexander is currently the VP of FP&A and Strategic Finance at Cullinan Oncology.

Alexander van Dijk attended Duke University from 2003 to 2007, where they earned a Bachelor's Degree in Alexander'story and Economics. Alexander then attended Duke University - The Fuqua School of Business from 2011 to 2013, where they earned a Master of Business Administration with a focus in Health Sector Management and Financial Analysis.